BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $55,881,000 | -24.2% | 635,302 | -16.3% | 0.58% | -21.1% |
| Q1 2021 | $73,768,000 | -48.2% | 758,691 | -40.3% | 0.73% | -35.7% |
| Q4 2020 | $142,490,000 | +12.6% | 1,270,529 | -6.9% | 1.13% | +18.3% |
| Q3 2020 | $126,501,000 | +18.8% | 1,364,631 | 0.0% | 0.96% | -1.5% |
| Q2 2020 | $106,441,000 | +12.8% | 1,364,631 | -15.4% | 0.97% | -23.5% |
| Q1 2020 | $94,345,000 | -21.7% | 1,613,294 | +7.2% | 1.27% | -15.3% |
| Q4 2019 | $120,533,000 | +9.5% | 1,504,599 | +0.4% | 1.50% | -0.8% |
| Q3 2019 | $110,096,000 | -22.1% | 1,498,516 | 0.0% | 1.51% | -52.1% |
| Q2 2019 | $141,355,000 | +17.8% | 1,498,516 | 0.0% | 3.16% | -5.4% |
| Q1 2019 | $119,956,000 | +55.5% | 1,498,516 | +4.7% | 3.34% | +4.4% |
| Q4 2018 | $77,142,000 | – | 1,430,949 | – | 3.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
| DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
| Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
| Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
| Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
| CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
| Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
| EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |